Painless abortion surgery pain
Conditions
Interventions
Anrikefon(A) Group:Group A received an intravenous bolus of Anruikefen at the 95% effective dose ( calculated based on body weight), followed by an intravenous bolus of propofol at 2 mg/kg.
Fentanyl (F) Group:Group F received an intravenous bolus of fentanyl at 1.5 µg/kg, followed by an intravenous bolus of propofol at 2 mg/kg.
Sponsors
The First People's Hospital of Yunnan Province
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Aged 20-40 years, with an American Society of Anesthesiologists (ASA) physical status classification of I-II; 2.Patients scheduled for painless induced abortion surgery; 3.Body Mass Index (BMI) 18-28 kg/m^²; 4.Gestational age <= 10 weeks; 5.Has provided written informed consent;
Exclusion criteria
Exclusion criteria: 1.Patients with known allergies to opioids, propofol, or anrikefon; 2.Chronic use of sedative or analgesic medications; 3.Severe cardiac, pulmonary, hepatic, or renal dysfunction; 4.Difficult airway, or fasting time < 6 hours; 5.Presence of conditions predisposing to postoperative nausea and vomiting (eg:vertigo); 6.Presence of psychiatric disorders or cognitive impairment that may impede cooperation with study assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Pain Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesic Rescue Medication Use;Perioperative Vital Signs;Use of Rescue Sedatives;recovery time;PACU length of stay;Incidence and Severity of Postoperative Nausea and Vomiting (PONV);Incidence and Severity of Postoperative Pruritus;Incidence and Severity of Postoperative Dizziness and Drowsiness;Satisfaction assessment; | — |
Countries
China
Contacts
Public ContactLuo Jing
The First People's Hospital of Yunnan Province
Outcome results
None listed